These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31512220)

  • 1. Reprogramming of Primary Human Cells to Induced Pluripotent Stem Cells Using Sendai Virus.
    Draper JM; Vivian JL
    Methods Mol Biol; 2020; 2066():217-234. PubMed ID: 31512220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells.
    Miere C; Devito L; Ilic D
    Methods Mol Biol; 2016; 1357():33-44. PubMed ID: 26246353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of Human Induced Pluripotent Stem Cells Using RNA-Based Sendai Virus System and Pluripotency Validation of the Resulting Cell Population.
    Chichagova V; Sanchez-Vera I; Armstrong L; Steel D; Lako M
    Methods Mol Biol; 2016; 1353():285-307. PubMed ID: 25697416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus Vector.
    Tsukamoto M; Kimura K; Tanaka M; Kuwamura M; Ohtaka M; Nakanishi M; Sugiura K; Hatoya S
    Mol Reprod Dev; 2020 Jun; 87(6):663-665. PubMed ID: 32424848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Patient-Specific induced Pluripotent Stem Cell from Peripheral Blood Mononuclear Cells by Sendai Reprogramming Vectors.
    Quintana-Bustamante O; Segovia JC
    Methods Mol Biol; 2016; 1353():1-11. PubMed ID: 25523810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of pluripotent stem cells by reprogramming human ocular fibroblasts under xeno-free conditions.
    Xiong Y; Liu Y; Ge J
    Arq Bras Oftalmol; 2018; 81(5):376-383. PubMed ID: 30208139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of Human Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells Using Sendai Virus.
    Soares FA; Pedersen RA; Vallier L
    Methods Mol Biol; 2016; 1357():23-31. PubMed ID: 25687300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
    Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
    Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming Methods Do Not Affect Gene Expression Profile of Human Induced Pluripotent Stem Cells.
    Trevisan M; Desole G; Costanzi G; Lavezzo E; Palù G; Barzon L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28117672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient RNA-Based Reprogramming of Disease-Associated Primary Human Fibroblasts into Induced Pluripotent Stem Cells.
    McGrath PS; McGarvey SS; Kogut I; Bilousova G
    Methods Mol Biol; 2020; 2117():271-284. PubMed ID: 31960386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of canine induced pluripotent stem cells under feeder-free conditions using Sendai virus vector encoding six canine reprogramming factors.
    Tsukamoto M; Kimura K; Yoshida T; Tanaka M; Kuwamura M; Ayabe T; Ishihara G; Watanabe K; Okada M; Iijima M; Nakanishi M; Akutsu H; Sugiura K; Hatoya S
    Stem Cell Reports; 2024 Jan; 19(1):141-157. PubMed ID: 38134923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient Generation of Non-Integration and Feeder-Free Induced Pluripotent Stem Cells from Human Peripheral Blood Cells by Sendai Virus.
    Ye H; Wang Q
    Cell Physiol Biochem; 2018; 50(4):1318-1331. PubMed ID: 30355953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of Footprint-Free Canine Induced Pluripotent Stem Cells Using Auto-Erasable Sendai Virus Vector.
    Tsukamoto M; Nishimura T; Yodoe K; Kanegi R; Tsujimoto Y; Alam ME; Kuramochi M; Kuwamura M; Ohtaka M; Nishimura K; Nakanishi M; Inaba T; Sugiura K; Hatoya S
    Stem Cells Dev; 2018 Nov; 27(22):1577-1586. PubMed ID: 30215317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced Pluripotent Stem Cell Generation from Blood Cells Using Sendai Virus and Centrifugation.
    Rim YA; Nam Y; Ju JH
    J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved Sendai viral system for reprogramming to naive pluripotency.
    Kunitomi A; Hirohata R; Arreola V; Osawa M; Kato TM; Nomura M; Kawaguchi J; Hara H; Kusano K; Takashima Y; Takahashi K; Fukuda K; Takasu N; Yamanaka S
    Cell Rep Methods; 2022 Nov; 2(11):100317. PubMed ID: 36447645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors.
    Ye L; Muench MO; Fusaki N; Beyer AI; Wang J; Qi Z; Yu J; Kan YW
    Stem Cells Transl Med; 2013 Aug; 2(8):558-66. PubMed ID: 23847002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a control human induced pluripotent stem cell line using the defective and persistent Sendai virus vector system.
    Zhou Z; Yoshimatsu S; Qian E; Ishikawa M; Sato T; Ohtaka M; Nakanishi M; Okano H
    Stem Cell Res; 2021 Oct; 56():102549. PubMed ID: 34598113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
    Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
    J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.